Mettler-Toledo International, Inc. (NYSE:MTD) Receives $1,419.55 Average Price Target from Analysts

Mettler-Toledo International, Inc. (NYSE:MTD) has earned an average recommendation of “Hold” from the thirteen analysts that are currently covering the stock, MarketBeat.com reports. Eight research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $1,419.5455.

A number of equities analysts have issued reports on the stock. Morgan Stanley initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price target for the company. Wells Fargo & Company upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. boosted their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Finally, Bank of America upped their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,382.47 on Friday. The business has a fifty day moving average of $1,392.93 and a 200 day moving average of $1,286.59. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,525.17. The firm has a market capitalization of $28.24 billion, a price-to-earnings ratio of 34.48, a price-to-earnings-growth ratio of 4.57 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The business had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. During the same period in the prior year, the company earned $10.21 earnings per share. The company’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,055 shares of the business’s stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider directly owned 187 shares of the company’s stock, valued at approximately $278,289.66. The trade was a 97.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Shawn Vadala sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total value of $1,511,000.00. Following the completion of the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,990,168. This represents a 15.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 19,565 shares of company stock valued at $28,683,737. 0.77% of the stock is owned by insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Several institutional investors have recently made changes to their positions in the company. Russell Investments Group Ltd. grew its holdings in shares of Mettler-Toledo International by 29.0% during the 1st quarter. Russell Investments Group Ltd. now owns 116,502 shares of the medical instruments supplier’s stock worth $137,548,000 after purchasing an additional 26,171 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its holdings in Mettler-Toledo International by 46.7% in the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier’s stock valued at $9,245,000 after buying an additional 2,493 shares during the period. Sound Income Strategies LLC lifted its position in Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after buying an additional 43 shares during the last quarter. LPL Financial LLC boosted its stake in Mettler-Toledo International by 16.3% during the first quarter. LPL Financial LLC now owns 5,404 shares of the medical instruments supplier’s stock worth $6,382,000 after buying an additional 758 shares during the period. Finally, Acadian Asset Management LLC increased its position in shares of Mettler-Toledo International by 84.9% during the first quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier’s stock valued at $2,965,000 after acquiring an additional 1,154 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.